Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Aug:68-69:355-365.
doi: 10.1016/j.matbio.2018.03.015. Epub 2018 Mar 19.

Endoplasmic reticulum stress in pulmonary fibrosis

Affiliations
Review

Endoplasmic reticulum stress in pulmonary fibrosis

Ankita Burman et al. Matrix Biol. 2018 Aug.

Abstract

Endoplasmic reticulum (ER) stress is associated with development and progression of fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). ER stress was first implicated in the pathogenesis of IPF >15 years ago with the discovery of disease-causing mutations in surfactant protein C, which result in a misfolded gene product in type II alveolar epithelial cells (AECs). ER stress and the unfolded protein response (UPR) have been linked to lung fibrosis through regulation of AEC apoptosis, epithelial-mesenchymal transition, myofibroblast differentiation, and M2 macrophage polarization. Although progress has been made in understanding the causes and consequences of ER stress in IPF and a number of chronic fibrotic disorders, further studies are needed to identify key factors that induce ER stress in important cell types and define critical down-stream processes and effector molecules that mediate ER stress-related phenotypes. This review discusses potential causes of ER stress induction in the lungs and current evidence linking ER stress to fibrosis in the context of individual cell types: AECs, fibroblasts, and macrophages. As our understanding of the relationship between ER stress and lung fibrosis continues to evolve, future studies will examine new strategies to modulate UPR pathways for therapeutic benefit.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Potential causes of ER stress.
Fig. 2.
Fig. 2.
Pro-fibrotic effects of ER stress in different cell types in lung fibrosis.

Similar articles

Cited by

References

    1. Mora AL, Rojas M, Pardo A, Selman M, Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease, Nat. Rev. Drug Discov 16 (11) (2017) 755–772. - PubMed
    1. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr., Kondoh Y, Myers J, Muller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schunemann HJ, An official ATS/ ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management, Am. J. Respir. Crit. Care Med 183 (6) (2011) 788–824. - PMC - PubMed
    1. Selman M, Pardo A, Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers, Proc. Am. Thorac. Soc 3 (4) (2006) 364–372. - PubMed
    1. Byrne AJ, Maher TM, Lloyd CM, Pulmonary macrophages: a new therapeutic pathway in Fibrosing lung disease? Trends Mol. Med 22 (4) (2016) 303–316. - PubMed
    1. Byrne AJ, Mathie SA, Gregory LG, Lloyd CM, Pulmonary macrophages: key players in the innate defence of the airways, Thorax 70 (12) (2015) 1189–1196. - PubMed

Publication types